WINTER SPRINGS, Fla., Oct. 26, 2017 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced FDA 510(k) clearance of its 3880 Magnetic Resonance Imaging (“MRI”) compatible patient vital ...
IRadimed Corporation offers steady revenue growth with 14 consecutive quarters of record revenue and a small dividend, despite recent stock price decline. IRMD's unique MRI-compatible IV infusion pump ...
A team of U.S. and South Korean researchers have developed an AI model called MSI-SEER that can not only predict microsatellite instability-high (MSI-H) tumors ...
Iradimed picked up an FDA nod for its MRI-compatible intravenous infusion pump system, which enables patients who can’t be disconnected from IV medication to undergo MRI scanning. The company will now ...
LONDON--(BUSINESS WIRE)--The anesthesia market is witnessing significant technological advancements that are helping the healthcare industry to improve the precision and effectiveness of anesthesia ...
Image-guided robotic procedures have taken large steps forward in recent years, but one area where they have yet to make inroads is MRI, the tool of choice for scanning soft tissue. The dangers of ...
Please provide your email address to receive an email when new articles are posted on . Boston Scientific announced that the FDA approved a subcutaneous implantable cardioverter defibrillator designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results